Supporting evidence
Dulaglutide × BMI
- Authoritative support
- 3
- Available studies
- 3
- Unavailable support
- 0
Available supporting studies
Study 1 · Limited
Dulaglutide may improve weight loss in obese patients with diabetes
Non randomized trial
- Comparison
- A case of a 27 year old ex sumo wrestler with type 2 diabetes and morbid obesity receiving dulaglutide.
- Duration / follow-up
- 26 weeks
Relevant effects
Absolute change
40
Absolute change
10.3
Study 2 · Limited
GLP-1 agonists reduce heart fat thickness in diabetes.
- Comparison
- Patients received semaglutide as part of their treatment regimen. · Patients received dulaglutide as part of their treatment regimen. · Patients received metformin as the control treatment.
- Duration / follow-up
- 12 weeks
Study 3 · Limited
Higher dulaglutide doses improve weight loss in type 2 diabetes
Rct
- Comparison
- Patients received once weekly dulaglutide 1.5 mg for 52 weeks. · Patients received once weekly dulaglutide 3.0 mg for 52 weeks. · Patients received once weekly dulaglutide 4.5 mg for 52 weeks.
- Duration / follow-up
- 52 weeks
Relevant effects
Absolute change
3.1 · 0.001
Absolute change
4 · 0.001
Absolute change
4.7 · 0.001